1. Home
  2. BOLT vs STAI Comparison

BOLT vs STAI Comparison

Compare BOLT & STAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLT
  • STAI
  • Stock Information
  • Founded
  • BOLT 2015
  • STAI 2011
  • Country
  • BOLT United States
  • STAI United States
  • Employees
  • BOLT N/A
  • STAI N/A
  • Industry
  • BOLT Biotechnology: Pharmaceutical Preparations
  • STAI
  • Sector
  • BOLT Health Care
  • STAI
  • Exchange
  • BOLT Nasdaq
  • STAI Nasdaq
  • Market Cap
  • BOLT 16.8M
  • STAI 19.0M
  • IPO Year
  • BOLT 2021
  • STAI N/A
  • Fundamental
  • Price
  • BOLT $5.91
  • STAI $0.65
  • Analyst Decision
  • BOLT Buy
  • STAI
  • Analyst Count
  • BOLT 3
  • STAI 0
  • Target Price
  • BOLT $50.00
  • STAI N/A
  • AVG Volume (30 Days)
  • BOLT 26.0K
  • STAI 682.4K
  • Earning Date
  • BOLT 08-12-2025
  • STAI 01-01-0001
  • Dividend Yield
  • BOLT N/A
  • STAI N/A
  • EPS Growth
  • BOLT N/A
  • STAI N/A
  • EPS
  • BOLT N/A
  • STAI N/A
  • Revenue
  • BOLT $3,638,000.00
  • STAI $542,166.00
  • Revenue This Year
  • BOLT N/A
  • STAI N/A
  • Revenue Next Year
  • BOLT $24.14
  • STAI N/A
  • P/E Ratio
  • BOLT N/A
  • STAI N/A
  • Revenue Growth
  • BOLT N/A
  • STAI N/A
  • 52 Week Low
  • BOLT $5.20
  • STAI $0.62
  • 52 Week High
  • BOLT $15.60
  • STAI $9.07
  • Technical
  • Relative Strength Index (RSI)
  • BOLT 47.01
  • STAI N/A
  • Support Level
  • BOLT $5.52
  • STAI N/A
  • Resistance Level
  • BOLT $6.21
  • STAI N/A
  • Average True Range (ATR)
  • BOLT 0.33
  • STAI 0.00
  • MACD
  • BOLT 0.04
  • STAI 0.00
  • Stochastic Oscillator
  • BOLT 48.67
  • STAI 0.00

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

About STAI ScanTech AI Systems Inc. Common stock

ScanTech AI Systems Inc is developing and deploying security screening systems that protect travelers and other public members from criminals, terrorists, and other bad actors. It has developed a proprietary Computed Tomography scanning system that uses fixed-gantry technology to detect explosives, weapons, narcotics, and other contraband.

Share on Social Networks: